Dr. Wes Wilson is a Canadian Tumor Immunologist & Cancer Researcher. In 2021 they received a Young Investigators award for their work on treating solid tumors with immunotherapy. They are currently a Marylou Imgram Scholar through ISAC for their research achievements and contributions to the field. They currently sit on Education and Training committees for various international standards groups. Wilson trained in Tumor Immunology at UWA and did their postdoctoral fellowship in CAR T cell therapy for both hematological malignancies and solid tumors at Penn Medicine. Their current work is focused on neuro-immunotherapy to help develop cellular therapy strategies for treating brain tumors (GBM, DMG/DIPG) in complex tumor microenvironment